These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2869449)

  • 21. Nadolol: a new beta-blocker that may increase patient compliance.
    Gever LN
    Nursing; 1980 Oct; 10(10):57. PubMed ID: 6106172
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 23. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE; Eff J; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066
    [No Abstract]   [Full Text] [Related]  

  • 24. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 27. Improved physical performance as a therapeutic objective in patients with angina.
    Ling AS; Groel JT
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):161S-166S. PubMed ID: 37870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long duration of action of metoprolol in the prolonged treatment of angina of effort].
    Floris B; Franchetta G; Palestini N; Pignotti M; Sonaglioni G; Verdecchia P; Beggi P; Bichisao E
    Boll Soc Ital Cardiol; 1981; 26(10):925-32. PubMed ID: 7349175
    [No Abstract]   [Full Text] [Related]  

  • 32. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract]   [Full Text] [Related]  

  • 34. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
    Sidorenko BA; Lupanov VP; Kulikova TV; Nekrutman EA; Matveeva LS
    Klin Med (Mosk); 1984 Nov; 62(11):44-51. PubMed ID: 6151611
    [No Abstract]   [Full Text] [Related]  

  • 37. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of two beta-adrenergic blocking drugs in angina pectoris.
    Stroescu V; Theodorini S; Creţescu R
    Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.